Literature DB >> 26820740

Assessment of left and right atrial 3D hemodynamics in patients with atrial fibrillation: a 4D flow MRI study.

Michael Markl1,2, Maria Carr3, Jason Ng4,5, Daniel C Lee3,4,5, Kelly Jarvis3,6, James Carr3, Jeffrey J Goldberger4,5,7.   

Abstract

Atrial fibrillation (AF) is associated with embolic stroke due to thrombus formation in the left atrium (LA). Based on the relationship of atrial stasis to thromboembolism and the marked disparity in pulmonary versus systemic thromboembolism in AF, we tested the hypothesis that flow velocity distributions in the left (LA) versus right atrium (RA) in patients with would demonstrate increased stasis. Whole heart 4D flow MRI was performed in 62 AF patients (n = 33 in sinus rhythm during imaging, n = 29 with persistent AF) and 8 controls for the assessment of in vivo atrial 3D blood flow. 3D segmentation of the LA and RA geometry and normalized velocity histograms assessed atrial velocity distribution and stasis (% of atrial velocities <0.2 m/s). Atrial hemodynamics were similar for RA and LA and significantly correlated (mean velocity: r = 0.64; stasis: r = 0.55, p < 0.001). RA and LA mean and median velocities were lower in AF patients by 15-33 % and stasis was elevated by 11-19 % compared to controls. There was high inter-individual variability in LA/RA mean velocity ratio (range 0.5-1.8) and LA/RA stasis ratio (range 0.7-1.7). Patients with a history of AF and in sinus rhythm showed most pronounced differences in atrial flow (reduced mean velocities, higher stasis in the LA). While there is no systematic difference in LA versus RA flow velocity profiles, high variability was noted. Further delineation of patient specific factors and/or regional atrial effects on the LA and RA flow velocity profiles, as well as other factors such as differences in procoagulant factors, may explain the more prevalent systemic versus pulmonary thromboembolism in patients with AF.

Entities:  

Keywords:  4D flow MRI; Atrial fibrillation; Blood flow; Stasis; Thromboembolism

Mesh:

Year:  2016        PMID: 26820740     DOI: 10.1007/s10554-015-0830-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

1.  Left atrial flow velocity distribution and flow coherence using four-dimensional FLOW MRI: a pilot study investigating the impact of age and Pre- and Postintervention atrial fibrillation on atrial hemodynamics.

Authors:  Jacob U Fluckiger; Jeffrey J Goldberger; Daniel C Lee; Jason Ng; Richard Lee; Amita Goyal; Michael Markl
Journal:  J Magn Reson Imaging       Date:  2013-01-04       Impact factor: 4.813

2.  Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.

Authors:  Peter Bernhardt; Harald Schmidt; Christoph Hammerstingl; Berndt Lüderitz; Heyder Omran
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

3.  Right atrial appendage function in patients with chronic nonvalvular atrial fibrillation.

Authors:  M Bilge; B Eryonucu; N Güler; R Erkoç
Journal:  Jpn Heart J       Date:  2000-07

4.  Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.

Authors:  A L Klein; R A Grimm; I W Black; D Y Leung; M K Chung; S E Vaughn; R D Murray; D P Miller; K L Arheart
Journal:  Ann Intern Med       Date:  1997-02-01       Impact factor: 25.391

5.  Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

6.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Right atrial appendage: forgotten part of the heart in atrial fibrillation.

Authors:  Orhan Ozer; Ibrahim Sari; Vedat Davutoglu
Journal:  Clin Appl Thromb Hemost       Date:  2008-10-07       Impact factor: 2.389

8.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

Authors:  W J Manning; D I Silverman; C S Keighley; P Oettgen; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

9.  Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation.

Authors:  D Y Leung; I W Black; G B Cranney; A P Hopkins; W F Walsh
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  13 in total

1.  Transcatheter aortic matryoshka doll: thrombosis.

Authors:  Levent Cerit
Journal:  Clin Res Cardiol       Date:  2016-11-28       Impact factor: 5.460

Review 2.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

Review 3.  Atrial Cardiopathy and Stroke Prevention.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

Review 4.  Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.

Authors:  Graham Peigh; Sanjiv J Shah; Ravi B Patel
Journal:  Curr Heart Fail Rep       Date:  2021-04-17

5.  Left Atrial 4D Blood Flow Dynamics and Hemostasis following Electrical Cardioversion of Atrial Fibrillation.

Authors:  Merih Cibis; Tomas L Lindahl; Tino Ebbers; Lars O Karlsson; Carl-Johan Carlhäll
Journal:  Front Physiol       Date:  2017-12-12       Impact factor: 4.566

Review 6.  Unravelling cardiovascular disease using four dimensional flow cardiovascular magnetic resonance.

Authors:  Vivian P Kamphuis; Jos J M Westenberg; Roel L F van der Palen; Nico A Blom; Albert de Roos; Rob van der Geest; Mohammed S M Elbaz; Arno A W Roest
Journal:  Int J Cardiovasc Imaging       Date:  2016-11-25       Impact factor: 2.357

7.  Cardiovascular imaging 2016 in the International Journal of Cardiovascular Imaging.

Authors:  Johan H C Reiber; Johan De Sutter; Paul Schoenhagen; Arthur E Stillman; Nico R L Vande Veire
Journal:  Int J Cardiovasc Imaging       Date:  2017-06       Impact factor: 2.357

8.  Mechanical dyssynchrony alters left ventricular flow energetics in failing hearts with LBBB: a 4D flow CMR pilot study.

Authors:  Jakub Zajac; Jonatan Eriksson; Urban Alehagen; Tino Ebbers; Ann F Bolger; Carl-Johan Carlhäll
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-02       Impact factor: 2.357

9.  Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Mark T Mills; Ciaran Grafton-Clarke; Gareth Williams; Rebecca C Gosling; Abdulaziz Al Baraikan; Andreas L Kyriacou; Paul D Morris; Julian P Gunn; Peter P Swoboda; Eylem Levelt; Vasiliki Tsampasian; Rob J van der Geest; Andrew J Swift; John P Greenwood; Sven Plein; Vass Vassiliou; Pankaj Garg
Journal:  Wellcome Open Res       Date:  2021-05-18

10.  4D flow MRI assessment of right atrial flow patterns in the normal heart - influence of caval vein arrangement and implications for the patent foramen ovale.

Authors:  Jehill D Parikh; Jayant Kakarla; Bernard Keavney; John J O'Sullivan; Gary A Ford; Andrew M Blamire; Kieren G Hollingsworth; Louise Coats
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.